Status: Recruiting
grouP O wholE blooD : storagE leSion impacT And infLammation
"Etablissement Français du Sang" (EFS) prepares labile blood products from blood donations that are separated by type (red blood cells, plasma and platelets). The "Centre de Transfusion Sanguine des Armées" (CTSA) produces an innovative labile blood product, LTO-WB, corresponding to group O leukocyte-free whole blood. The objective of the PEDESTAL EFS study is to compare the inflammatory and biological characteristics of blood products prepared by the EFS vs. the labile blood product prepared by the CTSA.
Participants needed: 30
Trial details
Age: 18-65Biological sex: AllType: InterventionalSponsor: Etablissement Français du SangUpdated: Aug 6, 2025Locations: 1
Eligibility criteria
Be in good health [+2]